Bibliography for: "Under a strategic agreement, the Center for Process Analytical Chemistry of the University of Washington will use Aspectrics' EP-IR MultiComponent 500 analyzers to develop advanced BTX"

"Under a strategic agreement, the Center for Process Analytical Chemistry of the University of Washington will use Aspectrics' EP-IR MultiComponent 500 analyzers to develop advanced BTX". Instrument Business Outlook. FindArticles.com. 01 Dec, 2009. http://findarticles.com/p/articles/mi_hb6656/is_13_15/ai_n29302016/

Instrument Business Outlook

View more issues:

Articles in Oct 15, 2006 issue of Instrument Business Outlook

• The clinical proteomic technology centers
• Sigma-Aldrich buys chiral chromatography firm
• Beckman Coulter expands chemistry offerings
• Beckman Coulter adds to assay miniaturization capabilities
• 3M acquires Biotrace
• VWR acquires Singaporean distributor
• Q2 operating profit decline for Life Science Index
• EU Industrial R&D Scoreboard: oil & gas R&D grows
• Government
• Metals
• Pharmaceuticals
• China
• Brazil
• EU
• Business Climate Survey: optimism amid uncertainty
• In April, IDEAL Industries, a manufacturer of professional quality tools, acquired Casella Measurement
• California Analytical Instruments acquired Liston Scientific, a provider of gas analyzers
• Applikon Analytical named five new distributors
• LumaSense Technologies acquired Innova AirTech Systems A/S in July
• Alesco's Scientific and Medical Division acquired App-Tek Group, a manufacturer of gas detection equipment
• ADS, a Nova Analytics company, acquired Severn Trent Pipeline Services
• Under a strategic agreement, the Center for Process Analytical Chemistry of the University of Washington will use Aspectrics' EP-IR MultiComponent 500 analyzers to develop advanced BTX
• Siemens
• Siemens
• ABB
• Severn Trent Services
• AppliTek NV
• Metara
• X-Rite
• SpectraSensors
• Baseline-MOCON
• SEQUENOM: Betty Dragon
• SEQUENOM: A. Michael Monko
• In August, Paul W. Hawran, CFO at Neurocrine Biosciences, joined SEQUENOM
• Luminex
• New England Biolabs will provide Solexa with certain key enzymes and other reagents for use with the Solexa Genome Analysis System
• Solexa
• In August, Joseph Whitters, former CFO of First Health Group, joined Solexa's Board
• A. Blaine Bowman, former president and CEO of Dionex, and Roy Whitfield, former CEO of Incyte, joined Solexa's Board
• SRU Biosystems stated in August that a district court rejected Corning's injunction and entered its proposal
• In August, Olympus signed an exclusive Japanese distribution agreement for VisEn Medical's fluorescence molecular tomography imaging systems
• Under a partnership agreement, Royal Philips Electronics and BG Medicine will develop molecular healthcare products
• Caliper Life Sciences
• Cambridge Research & Instrumentation and Invitrogen will jointly promote the use of CRi's Maestro small animal
• Caliper Life Sciences
• Axela Biosensors
• Kreatech Biotechnology BV is marketing QIAGEN NV's REPLI-g Whole Genome Amplification Kits in combination with its Universal Linkage System
• In July, Beckman Coulter acquired an in vitro diagnostics product license to all real-time PCR patents and pending patent applications controlled by Roche Diagnostics
• Invitrogen and Prodesse signed a license agreement in July for the first diagnostics assays
• In August, Fisher HealthCare became the exclusive distributor of Nanogen's MGB
• A trust managed by Drug Royalty acquired an interest in royalties on Nanogen's MGB technology for 5' nuclease real-time PCR applications for biomedical research for $20 million
• Under a strategic alliance announced in August, Warnex will combine its pathogen detection kits and software with Eppendorf AG's Mastercycler ep realplex real-time PCR system
• Stratagene entered into a joint development and license agreement with Rosetta Inpharmatics, a unit of Merck & Co., to create an automated solution for the isolation of nucleic acids from a variety of clinical samples
• In September, Takara Bio and its Clontech Laboratories subsidiary entered into license agreements with Applied Biosystems
• In the first half of 2006, Cepheid's total revenues declined 2% to $40.0 million
• Enzo Biochem acquired licenses from LBS Technologies for linear amplification technology
• Applied Biosystems
• Applied Biosystems
• NuGEN
• As part of a research collaboration with Jacobi Medical Center to develop a genetic screening platform for neonatal, prenatal and maternal/adult healthcare
• PerkinElmer entered into multi-year research agreements with John Hopkins University and the University of Birmingham, UK
• PerkinElmer entered into a multi-year license and research collaboration agreement with the University of Leicester, UK
• Waters
• Bruker Daltonics was named the exclusive worldwide manufacturer of Ibis Pharmaceuticals' T5000 biosensor systems
• Bruker Daltonics licensed Health Discovery's Support Vector Machine pattern recognition technology
• Under an expanded cooperative marketing agreement, Proteome Systems will provide Agilent
• Cohesive Technologies entered into a collaborative agreement with the Mayo Clinic
• Waters will develop its ACQUITY UPLC System software controls for use with Applied Biosystems/MDS SCIEX's
• Thermo Electron
• Thermo Electron
• Varian
• Bruker Daltonics
• Bruker Daltonics
• China's Ministry of Health, PerkinElmer
• Market profile: animal ultrasound imaging
• The bottom line